Related Experiment Video
Updated: May 5, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
MicroRNA-183 suppresses retinoblastoma cell growth, invasion and migration by targeting LRP6
Jianwen Wang1, Xiaochun Wang2, Zhongji Li1
1Eye Hospital, First Affiliated Hospital, Harbin Medical University, China.
Abstract:
Our study demonstrates the downregulation of microRNA-183 (miR-183) in retinoblastoma (RB) tissues and RB cell lines compared with normal retinal tissues. The ectopic expression of miR-183 in the RB cell lines Y79, SO-RB50 and WERI-RB1 suppresses cell viability, migration and invasion. Furthermore, the Wnt co-receptor low-density lipoprotein receptor-related protein 6 (LRP6) was identified as a new target of miR-183, and restoration of the expression of LRP6 rescues the effects induced by miR-183 in RB cells. These results indicate that miR-183 targets and downregulates LRP6 in the growth, migration and invasion of RB cells.
Insights
MicroRNA-183 (miR-183) is downregulated in retinoblastoma (RB). Restoring miR-183 suppresses RB cell growth and invasion by targeting low-density lipoprotein receptor-related protein 6 (LRP6).
Area of Science:
- Ophthalmology
- Molecular Biology
- Oncology
Background:
- Retinoblastoma (RB) is a pediatric eye cancer.
- The role of microRNAs (miRNAs) in RB pathogenesis is under investigation.
- MicroRNA-183 (miR-183) has been implicated in various cancers.
Purpose of the Study:
- To investigate the role of miR-183 in retinoblastoma.
- To identify potential targets of miR-183 in RB cells.
- To explore miR-183 as a therapeutic target for RB.
Main Methods:
- Quantitative real-time PCR to assess miR-183 expression in RB tissues and cell lines.
- Cell viability, migration, and invasion assays in RB cell lines with ectopic miR-183 expression.
- Western blotting and luciferase reporter assays to validate LRP6 as a direct target of miR-183.
Main Results:
- miR-183 expression was significantly downregulated in retinoblastoma tissues and cell lines compared to normal retinal tissues.
- Ectopic expression of miR-183 suppressed cell viability, migration, and invasion in RB cell lines (Y79, SO-RB50, WERI-RB1).
- Low-density lipoprotein receptor-related protein 6 (LRP6) was identified as a direct target of miR-183, and its restoration rescued the inhibitory effects of miR-183.
Conclusions:
- miR-183 acts as a tumor suppressor in retinoblastoma.
- miR-183 inhibits RB cell growth, migration, and invasion by downregulating LRP6.
- Targeting the miR-183/LRP6 pathway may offer a novel therapeutic strategy for retinoblastoma.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Experimental RNAi
Negative Regulator Molecules

